Medication Utilization and Lung Function Changes after Initiation of
Treatment with Elexacaftor/Tezacaftor/Ivacaftor
- Richard De Vuyst,
- Charissa Kam
, - Cameron McKinzie,
- Charles Esther
Richard De Vuyst
The University of North Carolina at Chapel Hill
Corresponding Author:richard-devuyst@ouhsc.edu
Author ProfileCharissa Kam
The University of North Carolina at Chapel Hill
Author ProfileCameron McKinzie
The University of North Carolina at Chapel Hill
Author ProfileCharles Esther
The University of North Carolina at Chapel Hill
Author ProfileSubmitted to Pediatric Pulmonology 18 Feb 2024Review(s) Completed, Editorial Evaluation Pending
20 Feb 2024Editorial Decision: Revise Major
18 Mar 2024Submission Checks Completed
18 Mar 2024Assigned to Editor
18 Mar 2024Review(s) Completed, Editorial Evaluation Pending
18 Mar 2024Reviewer(s) Assigned
07 Apr 2024Editorial Decision: Accept
